Republic Technologies Announces 2025 AGSM Results

Republic Technologies Announces 2025 AGSM Results

Republic Technologies Inc. (CSE: DOCT,OTC:DOCKF) (FSE: 7FM0) (the "Company" or "Republic") is pleased to announce that all matters put forth at the Company's Annual General and Special Meeting of Shareholders (the "Meeting") held on August 19, 2025 were approved by its shareholders.

The Company's shareholders voted to fix the number of directors of the Company at four and elected the following four nominees to the board of directors: Daniel Liu, Hongming Luo, Tianrui Zhang and Litong Cao. Each of the nominees will hold office until the next annual meeting of shareholders, unless he or she sooner ceases to hold office.

The shareholders appointed Charlton & Company, CPA as the auditor of the Company.

The shareholders also passed (i) an ordinary resolution approving the adoption of a new 20% rolling long-term incentive plan; and (ii) a special resolution approving the deletion and replacement of the Company's Articles. A copy of the Company's Articles is available under the Company's profile on SEDAR+ (www.sedarplus.ca).

Additional information regarding each of the items approved at the Meeting is set out in the Company's Information Circular dated July 8, 2025, that is available on SEDAR+ (www.sedarplus.ca) under the Company's profile.

About Republic Technologies Inc.

Republic Technologies is a publicly traded technology company integrating Ethereum infrastructure into the global economy. Backed by an ETH-denominated treasury, we operate proprietary validator and attestation networks to safeguard data integrity for universal applications.

On behalf of the Board of Directors,
Daniel Liu, Chief Executive Officer
Email: daniel@republictech.io
https://republictech.io/

Neither the Canadian Securities Exchange nor its Regulation Services Provider has reviewed or accepts responsibility for the accuracy or adequacy of this release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/263290

News Provided by Newsfile via QuoteMedia

DOCT:CNX
The Conversation (0)
beyond medical

Beyond Medical Technologies

Keeping Canadians Healthy and Safe

Keeping Canadians Healthy and Safe Keep Reading...
Seegnal (TSXV:SEGN)

Seegnal Presents Real-World Evidence on Reducing Fall Risk in Geriatric Patients at Caltcm Summit

Seegnal Inc. (TSXV: SEGN) ("Seegnal" or the "Corporation"), a global leader in AI-enhanced prescription intelligence, today announced real-world clinical results demonstrating how medication governance may reduce fall-risk drivers in older adults -- a significant clinical and financial challenge... Keep Reading...
Cardiologist wearing virtual reality glasses.

Top 3 Medical Device ETFs for Investors in 2026

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or... Keep Reading...
Stethoscope connected to a phone with medical data overlay.

Top 3 Small-cap Medical Device Stocks (Updated January 2026)

The growing prevalence of chronic diseases like cancer and diabetes is driving increasing innovation in medical device technology. In 2024 alone, 30 new devices were approved by the US Food and Drug Administration (FDA).Wearable medical devices and the use of artificial intelligence in medical... Keep Reading...
Scientists working in a modern medical research laboratory.

Pathways to Commercialising Biotech Innovations

In the medical technology industry, innovation is only the first step. While key to long-term success, innovation is only as good as a company’s commercialisation strategy. Once a technology has been developed and proven, the organisation must then embark on a process to commercialise it for... Keep Reading...
Medical devices on a desk.

How to Invest in Medical Device Stocks and ETFs

The medical device market offers investors unique exposure to the overall life science space, especially in an era of fast-growing tech advancements in healthcare.This industry covers a wide range of health and medical instruments and equipment used in the treatment, mitigation, diagnosis and... Keep Reading...
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians. BlinkLab states in its Wednesday (March 12) release that the study is the largest digital... Keep Reading...

Interactive Chart

Latest Press Releases

Related News